Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
A mouse-brain-slice study found different diazepam responses in two models with superficially similar electrical discharges.
A rat enzyme study found that several organophosphates did not produce one uniform effect on drug-metabolizing pathways.
A rat study found higher midazolam exposure after vonoprazan, providing an interaction signal rather than a human dosing rule.
A receptor study illustrates why resemblance to a benzodiazepine-binding pharmacophore does not establish an identical binding mechanism.
A multicenter retrospective study associated adjunct dexmedetomidine with longer ICU stay, while treatment selection left causal uncertainty.
A nonrandomized primary-care comparison reported less benzodiazepine prescribing with an integrative approach, while follow-up sleep findings remained mixed.
A three-state mortality study used benzodiazepines as a comparator and found that declining opioid death rates were not clearly distinct from comparator trends.
A pilot study linked laboratory co-detection patterns with social data and found ordering practice to be the strongest predictor in its model.
A survey of child and adolescent psychiatrists describes caution about lorazepam for sleep problems, while leaving treatment efficacy unresolved.
A French study of adults aged at least 75 with advanced kidney disease identified long-term benzodiazepines among medications warranting reassessment.
A pediatric trial found increased somnolence with a ketamine-midazolam regimen without a significant improvement in reported procedural pain.
A rat experiment found worsened blood-gas changes when oxycodone and diazepam were administered together.
The RACKED paper describes a planned comparison of intramuscular ketamine with midazolam plus haloperidol; it does not report treatment results.
A pediatric status epilepticus review describes continuous EEG as central to assessing seizure control during anesthetic infusions.
A systematic review examined withdrawal assessment after prolonged opioid and sedative infusions. A positive score still required interpretation within the clinical course.
A family-based clinical series connected exaggerated startle with glycine-receptor variants. Treatment response accompanied genetic and clinical evidence rather than replacing it.
A prospective transport-team study described feasible premedication and intubation conditions. Favorable conditions did not mean absence of procedural complications.
A medicines-record study distinguished as-needed prescriptions from recorded doses. Counting orders alone could overstate actual exposure during the reviewed month.
A small study compared EEG measures with later recall reports. Drug-related differences in an established index highlighted limits of applying one number across sedatives.
Five participants discontinued hypnotics in a small feasibility series. Masking the schedule occurred with consent and alongside behavioral treatment, not as an isolated or covert intervention.
A record review found imperfect agreement between documented history and urine screens. A mismatch did not independently establish deception or a clinically significant exposure.
A small crossover study found that prolonged fasting affected several metabolic steps differently. A single statement that fasting speeds or slows all midazolam metabolism would miss the findings.
A phase-one study measured midazolam before and during lenvatinib treatment. Timing mattered to the numerical ratios, even though the overall interpretation was a limited interaction.
An interaction study in psoriasis measured drug disposition before and during treatment. Improved inflammation did not automatically produce a meaningful change in midazolam exposure.
A survey found an association between benzodiazepine detection and reported overdose. Urine detection could not establish simultaneous exposure during the earlier event.
A clinical perspective argued that sedation practice, screening, family contact, and environmental design all matter to delirium prevention. It did not test a single architecture or drug intervention.
A hospital study found associations for several medicines but no increased benzodiazepine risk in its analyses. A negative association finding did not prove that every hematologic reaction is impossible.
A small observational study associated high-flow nasal oxygen with improved oxygen-saturation measures. It did not isolate the respiratory effect of either sedative.
A poisoning case distinguished clinical seizure suppression from electrical seizure control. Improvement in visible movement did not establish that status epilepticus had ended.
A randomized cardiac-procedure study found delayed platelet inhibition with fentanyl. Because all participants received midazolam, the trial did not isolate a midazolam interaction.